Glucose-Na-K Baxter 50 mg/ml infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

glucose-na-k baxter 50 mg/ml infusionsvæske, opløsning

baxter a/s - glucosemonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid - infusionsvæske, opløsning - 50 mg/ml

Sitagliptin / Metformin hydrochloride Mylan Den Europæiske Union - dansk - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Kalium-natrium-glucose "Braun" 1,492+2,338+55 mg/ml infusionsvæske Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

kalium-natrium-glucose "braun" 1,492+2,338+55 mg/ml infusionsvæske

b. braun melsungen - glucosemonohydrat, kaliumchlorid, natriumchlorid - infusionsvæske - 1,492+2,338+55 mg/ml

Kalium-Natrium-Glucose "Fresenius Kabi" infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

kalium-natrium-glucose "fresenius kabi" infusionsvæske, opløsning

fresenius kabi ab - glucosemonohydrat, kaliumchlorid, magnesiumchloridhexahydrat, natriumacetattrihydrat, natriumchlorid - infusionsvæske, opløsning

bicaVera 1,5 % Glucose, 1,25 mmol/l calcium peritonealdialysevæske Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bicavera 1,5 % glucose, 1,25 mmol/l calcium peritonealdialysevæske

fresenius medical care deutschland gmbh - calciumchloriddihydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske

bicaVera 1,5% Glucose, 1,75 mmol/l calcium peritonealdialysevæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bicavera 1,5% glucose, 1,75 mmol/l calcium peritonealdialysevæske, opløsning

fresenius medical care deutschland gmbh - calciumchlorid, vandfrit, glucosemonohydrat, magnesiumchloridhexahydrat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske, opløsning

bicaVera 2,3% Glucose, 1,75 mmol/l calcium peritonealdialysevæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bicavera 2,3% glucose, 1,75 mmol/l calcium peritonealdialysevæske, opløsning

fresenius medical care deutschland gmbh - calciumchlorid, vandfrit, glucosemonohydrat, magnesiumchloridhexahydrat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske, opløsning

bicaVera 4,25 % Glucose, 1,25 mmol/l calcium peritonealdialysevæske Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bicavera 4,25 % glucose, 1,25 mmol/l calcium peritonealdialysevæske

fresenius medical care deutschland gmbh - calciumchloridhexahydrat, glucosemonohydrat, magnesiumchloridhexahydrat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske

bicaVera 4,25% Glucose, 1,75 mmol/l calcium peritonealdialysevæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bicavera 4,25% glucose, 1,75 mmol/l calcium peritonealdialysevæske, opløsning

fresenius medical care deutschland gmbh - calciumchlorid, vandfrit, glucosemonohydrat, magnesiumchloridhexahydrat, natriumchlorid, natriumhydrogencarbonat - peritonealdialysevæske, opløsning

Sitagliptin / Metformin hydrochloride Accord Den Europæiske Union - dansk - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, type 2 - narkotika anvendt i diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. - , trepersoners-kombinationsbehandling) som supplement til diæt og motion hos patienter, der ikke er tilstrækkeligt kontrolleret på deres maksimal tolereret dosis af metformin og et sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.